New study aims to find best pain block for hip surgery patients

NCT ID NCT07180979

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two types of nerve blocks (PENG block vs. a combination of lumbar and sacral ESPB) to see which provides better pain control after total hip replacement. Ninety adults aged 65 and older will be randomly assigned to receive one of the blocks during surgery. Researchers will measure opioid use, pain scores, and how quickly patients can walk in the first 48 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ropivacaine

What this could lead to

If one nerve block proves better, it could mean less pain, less opioid use, and faster walking after hip replacement surgery.

What could go wrong

This is a small, early-phase trial (90 people) comparing two established techniques. The difference may be small or not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP PAIN CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthropathy osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Poznan University of Medical Sciences

    RECRUITING

    Poznan, 62-701, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••